Neuroprotective effect of a new DJ-1-binding compound against neurodegeneration in Parkinson's disease and stroke model rats

Molecular Neurodegeneration

Volumn 6, Issue 1, 2011, Pages

  Kitamura, Yoshihisa ^a   Watanabe, Shotaro ^b   Taguchi, Masanobu ^a   Takagi, Kentaro ^a   Kawata, Takuya ^a   Takahashi Niki, Kazuko ^b   Yasui, Hiroyuki ^a   Maita, Hiroshi ^b   Iguchi Ariga, Sanae Mm ^b   Ariga, Hiroyoshi ^b  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

6 HYDROXYLDOPAMINE; DJ 1 BINDING COMPOUND 23; DJ 1 PROTEIN; DOPAMINE DERIVATIVE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CELL DEATH; COMPUTER MODEL; CONTROLLED STUDY; FLUORESCENCE SPECTROSCOPY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

MUS; RATTUS;

EID: 79959973394     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-6-48     Document Type: Article

References (44)

1. DJ-1, a novel oncogene which transforms mouse NIH3T3 cells in cooperation with ras. D Nagakubo T Taira H Kitaura M Ikeda K Tamai SMM Iguchi-Ariga H Ariga, Biochem Biophys Res Commum 1997 231 509 513 10.1006/bbrc.1997.6132 (Pubitemid 27214343)
2. Mutations in the DJ-1 gene associated with autosomal recessive early-onset Parkinsonism. V Bonifati P Rizzu MJ van Baren O Schaap GJ Breedveld E Krrieger MC Dekker F Squitieri P Ibanez M Joosse JW van Dongen N Vanacore JC van Swieten A Brice G Meco CM van Duijn BA Oostra P Heutink, Science 2003 299 256 259 10.1126/science.1077209 12446870 (Pubitemid 36131051)
3. DJ-1 positively regulates the androgen receptor by impairing the binding of PIASx alpha to the receptor. K Takahashi T Taira T Niki C Seino SMM Iguchi-Ariga H Ariga, J Biol Chem 2001 276 37556 37563 10.1074/jbc.M101730200 11477070
4. DJBP: A novel DJ-1-binding protein, negatively regulates the androgen receptor by recruiting histone deacetylase complex, and DJ-1 antagonizes this inhibition by abrogation of this complex. T Niki K Takahashi-Niki T Taira SMM Iguchi-Ariga H Ariga, Mol Cancer Res 2003 1 247 261 12612053 (Pubitemid 36292610)
5. DJ-1 restores p53 transcription activity inhibited by Topors/p53BP3. Y Shinbo T Taira T Niki SMM Iguchi-Ariga H Ariga, Int J Oncol 2005 26 641 648 15703819
6. DJ-1 transcriptionally up-regulates the human tyrosine hydroxylase by inhibiting the sumoylation of pyrimidine tract-binding protein-associated splicing factor. N Zhong CY Kim P Rizzu C Geula DR Porter EN Pothos F Squitieri P Heutink J Xu, J Biol Chem 2006 281 20940 20948 10.1074/jbc.M601935200 16731528 (Pubitemid 44115435)
7. DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2. CM Clements RS McNally BJ Conti TW Mak JP Ting, Proc Natl Acad Sci USA 2006 103 15091 15096 10.1073/pnas.0607260103 17015834 (Pubitemid 44583169)
8. DJ-1 binds androgen receptor directly and mediates its activity in hormonally treated prostate cancer cells. JE Tillman J Yuan G Gu L Fazli R Ghosh AS Flynt M Gleave PS Rennie S Kasper, Cancer Res 2007 67 4630 4637 10.1158/0008-5472.CAN-06-4556 17510388 (Pubitemid 46910167)
9. Human DJ-1-specific transcriptional activation of tyrosine hydroxylase gene. S Ishikawa T Taira K Takahashi-Niki T Niki H Ariga SMM Iguchi-Ariga, J Biol Chem 2010 285 39718 39731 10.1074/jbc.M110.137034 20938049
10. DJ-1 has a role in antioxidative stress to prevent cell death. T Taira Y Saito T Niki SMM Iguchi-Ariga K Takahashi H Ariga, EMBO Rep 2004 5 213 218 10.1038/sj.embor.7400074 14749723 (Pubitemid 38401204)
11. Down regulation of DJ-1 enhances cell death by oxidative stress, ER stress, and proteasome inhibition. T Yokota K Sugawara K Ito R Takahashi H Ariga H Mizusawa, Biochem Biophys Res Commun 2003 312 1342 1348 10.1016/j.bbrc.2003. 11.056 14652021 (Pubitemid 37490964)
12. The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. RM Canet-Aviles MA Wilson DW Miller R Ahmad C McLendon S Bandyopadhyay MJ Baptista D Ringe GA Petsko MR Cookson, Proc Natl Acad Sci USA 2004 101 9103 9108 10.1073/pnas.0402959101 15181200 (Pubitemid 38781618)
13. Sensitivity to oxidative stress in DJ-1-deficient dopamine neurons: An ES derived cell model of primary Parkinsonism. C Martinat S Shendelman A Jonason T Leete MF Beal L Yang T Floss A Abeliovich, PLoS Biol 2004 2 327 10.1371/journal.pbio.0020327 15502868
14. DJ-1 is a redox-dependent molecular chaperone that inhibits alpha-synuclein aggregate formation. S Shendelman A Jonason C Martinat T Leete A Abeliovich, PLoS Biol 2004 2 362 10.1371/journal.pbio.0020362 15502874
15. Reduced anti-oxidative stress activities of DJ-1 mutants found in Parkinson's disease patients. K Takahashi-Niki T Niki T Taira SMM Iguchi-Ariga H Ariga, Biochem Biophys Res Commun 2004 320 389 397 10.1016/j.bbrc.2004.05.187 15219840 (Pubitemid 38798879)
16. The oxidation state of DJ-1 regulates its chaperone activity toward -synuclein. W Zhou M Zhu MA Wilson GA Petsko AL Fink, J Mol Biol 2006 356 1036 1048 10.1016/j.jmb.2005.12.030 16403519 (Pubitemid 43145955)
17. Oxidative status of DJ-1-dependent activation of dopamine synthesis through interaction of tyrosine hydroxylase and 4-dihydroxy-L-phenylalanine (L-DOPA) decarboxylase with DJ-1. S Ishikawa T Taira T Niki K Takahashi-Niki C Maita H Maita H Ariga SMM Iguchi-Ariga, J Biol Chem 2009 284 28832 28844 10.1074/jbc.M109.019950 19703902
18. The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease. R Bandopadhyay AE Kingsbury MR Cookson AR Reid IM Evans AD Hope AM Pittman T Lashley R Canet-Aviles DW Miller C McLendon C Strand AJ Leonard PM Abou-Sleiman DG Healy H Ariga NW Wood R de Silva T Revesz JA Hardy AJ Lees, Brain 2004 127 420 430 10.1093/brain/awh054 14662519 (Pubitemid 38160326)
19. Oxidative damage of DJ-1 is linked to sporadic Parkinson and Alzheimer diseases. J Choi MC Sullards JA Olzmann HD Rees ST Weintraub DE Bostwick M Gearing AI Levey LS Chin L Li, J Biol Chem 2006 281 10816 10824 10.1074/jbc.M509079200 16517609 (Pubitemid 43855504)
20. PARK7 DJ-1 protects against degeneration of nigral dopaminergic neurons in Parkinson's disease rat model. M Inden T Taira Y Kitamura T Yanagida D Tsuchiya K Takata D Yanagisawa K Nishimura T Taniguchi Y Kiso K Yoshimoto T Agatsuma S Koide-Yoshida SMM Iguchi-Ariga S Shimohama H Ariga, Neurobiol Dis 2006 24 144 158 10.1016/j.nbd.2006.06.004 16860563 (Pubitemid 44416214)
21. DJ-1 protects against neurodegeneration caused by focal cerebral ischemia and reperfusion in rats. D Yanagisawa Y Kitamura M Inden K Takata T Taniguchi S Morikawa M Morita T Inubushi I Tooyama T Taira SMM Iguchi-Ariga A Akaike H Ariga, J Cereb Blood Flow Metab 2007 28 563 578 17882163
22. DJ-1 protects the nigrostriatal axis from the neurotoxin MPTP by modulation of the AKT pathway. H Aleyasin MW Rousseaux PC Marcogliese SJ Hewitt I Irrcher AP Joselin M Parsanejad RH Kim P Rizzu SM Callaghan RS Slack TW Mak DS Park, Proc Natl Acad Sci USA 2010 107 3186 3191 10.1073/pnas.0914876107 20133695
23. DJ-1-binding compounds prevent oxidative stress-induced cell death and movement defect in Parkinson's disease model rats. S Miyazaki T Yanagida K Nunome S Ishikawa M Inden Y Kitamura S Nakagawa T Taira K Hirota M Niwa SMM Iguchi-Ariga H Ariga, J Neurochem 2008 105 2418 2434 10.1111/j.1471-4159.2008. 05327.x 18373560 (Pubitemid 351782268)
24. Protection against oxidative stress-induced neurodegeneration by a modulator for DJ-1, the wild-type of familial Parkinson's disease-linked PARK7. T Yanagida Y Kitamura K Yamane K Takahashi K Takata D Yanagisawa H Yasui T Taniguchi T Taira T Honda H Ariga, J Pharmacol Sci 2009 109 463 468 10.1254/jphs.08323SC 19276614
25. Oxidative neurodegeneration is prevented by UCP0045037, an allosteric modulator for the reduced form of DJ-1, a wild-type of familial Parkinson's disease-linked PARK7. K Yamane Y Kitamura T Yanagida K Takata D Yanagisawa T Taniguchi T Taira H Ariga, Int J Mol Sci 2009 10 4789 804 10.3390/ijms10114789 20087465
26. The crystal structure of DJ-1, a protein related to male fertility and Parkinson's disease. K Honbou NN Suzuki M Horiuchi T Niki T Taira H Ariga F Inagaki, J Biol Chem 2003 278 31380 31384 10.1074/jbc.M305878200 12796482 (Pubitemid 36994658)
27. The 1.1-A resolution crystal structure of DJ-1, the protein mutated in autosomal recessive early onset Parkinson's disease. MA Wilson JL Collins Y Hod D Ringe GA Petsko, Proc Natl Acad Sci USA 2003 100 9256 9261 10.1073/pnas.1133288100 12855764 (Pubitemid 37033916)
28. Mechanism of 6-hydroxydopamine neurotoxicity. Y Glinka M Gassen MB Youdim, J Neural Transm 1997 50 Suppl 55 66 (Pubitemid 27055928)
29. Iron, brain ageing and neurodegenerative disorders. L Zecca MB Youdim P Riederer JR Connor RR Crichton, Nat Rev Neurosci 2004 5 863 873 15496864 (Pubitemid 39482155)
30. Neurodegeneration of mouse nigrostriatal dopaminergic system induced by repeated oral administration of rotenone is prevented by 4-phenylbutyrate, a chemical chaperone. M Inden Y Kitamura H Takeuchi T Yanagida K Takata Y Kobayashi T Taniguchi K Yoshimoto M Kaneko Y Okuma T Taira H Ariga S Shimohama, J Neurochem 2007 101 1491 1504 10.1111/j.1471-4159.2006.04440.x 17459145 (Pubitemid 46848844)
31. Parkinsonian rotenone mouse model: Reevaluation of long-term administration of rotenone in C57BL/6 mice. M Inden Y Kitamura M Abe A Tamaki K Takata T Taniguchi, Biol Pharm Bull 2011 34 92 96 10.1248/bpb.34.92 21212524
32. DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2. CM Clements RS McNally BJ Conti TW Mak JP Ting, Proc Natl Acad Sci USA 2006 103 15091 1506 10.1073/pnas.0607260103 17015834
33. DJ-1, a novel regulator of the tumor suppressor PTEN. RH Kim M Peters Y Jang W Shi M Pintilie GC Fletcher C DeLuca J Liepa L Zhou B Snow RC Binari AS Manoukian MR Bray FF Liu MS Tsao TW Mak, Cancer Cell 2005 7 263 273 10.1016/j.ccr.2005.02.010 15766664 (Pubitemid 40568685)
34. Oxidation of DJ-1-dependent cell transformation through direct binding of DJ-1 to PTEN. YC Kim H Kitaura T Taira SMM Iguchi-Ariga H Ariga, Int J Oncol 2009 35 1331 1341 19885556
35. DJ-1 immunoreactivity in human brain astrocytes is dependent on infarct presence and infarct age. SJ Mullett RL Hamilton DA Hinkle, Neuropathology 2009 29 125 131 10.1111/j.1440-1789.2008.00955.x 18647263
36. Induction of Parkinson disease-related proteins in motor neurons after transient spinal cord ischemia in rabbits. M Sakurai T Kawamura H Nishimura H Suzuki F Tezuka K Abe, J Cereb Blood Flow Metab 2009 29 752 758 10.1038/jcbfm.2008.167 19142195
37. Proteasome mediates dopaminergic neuronal degeneration, and its inhibition causes alpha-synuclein inclusions. H Sawada R Kohno T Kihara Y Izumi N Sakka M Ibi M Nakanishi T Nakamizo K Yamakawa H Shibasaki N Yamamoto A Akaike M Inden Y Kitamura T Taniguchi S Shimohama, J Biol Chem 2004 279 10710 10719 14672949 (Pubitemid 38372684)
38. Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway. R Deumens A Blokland J Prickaerts, Exp Neurol 2002 175 303 317 10.1006/exnr.2002.7891 12061862 (Pubitemid 34634286)
39. Disease model: Parkinson's disease. S Shimohama H Sawada Y Kitamura T Taniguchi, Trends Mol Med 2003 9 360 365 10.1016/S1471-4914(03)00117-5 12928038 (Pubitemid 37040032)
40. Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway. R Deumens A Blokland J Prickaerts, Exp Neurol 2002 175 303 317 10.1006/exnr.2002.7891 12061862 (Pubitemid 34634286)
41. Olfactory ensheathing cell transplantation restores functional deficits in rat model of Parkinson's disease: a cotransplantation approach with fetal ventral mesencephalic cells. AK Agrawal S Shukla RK Chaturvedi K Seth N Srivastava A Ahmad PK Seth, Neurobiol Dis 2004 16 516 526 10.1016/j.nbd.2004.04. 014 15262263 (Pubitemid 38942984)
42. Prolonged blockade of NMDA or mGluR5 glutamate receptors reduces nigrostriatal degeneration while inducing selective metabolic changes in basal ganglia circuitry in a rodent model of Parkinson's disease. MT Armentero R Fancellu G Nappi P Bramanti F Blandini, Neurobiol Dis 2006 22 1 9 10.1016/j.nbd.2005.09.010 16289868
43. Cystain C prevents degeneration of rat nigral dopaminergic neurons: in vitro and in vivo studies. L Xu J Sheng Z Tang X Wu Y Yu H Guo Y Shen C Zhou L Paraoan J Zhou, Neurobiol Dis 2005 18 152 165 10.1016/j.nbd.2004.08.012 15649706 (Pubitemid 40092905)
44. Behavioral and anatomical effects of long-term l-dihydrophenylanine (l-DOPA) administration in rats with unilateral lesions of nigrostriatal system. A Mura M Mintz J Feldon, Exp Neurol 2002 177 252 264 10.1006/exnr.2002.7976 12429227 (Pubitemid 35356838)